Development of risk assessment tool for unplanned readmission within one year after colorectal cancer surgery in patients under enhanced recovery after surgery mode
10.3760/cma.j.issn.1674-2907.2018.02.004
- VernacularTitle:加速康复外科模式下结直肠癌患者术后1年内非计划性再入院风险评估工具的构建
- Author:
Jie YANG
1
;
Jinhua FENG
;
Ka LI
Author Information
1. 四川大学华西医院胃肠外科
- Keywords:
Colorectal neoplasms;
Enhanced recovery after surgery;
Unplanned readmission;
Risk assessment;
Delphi method
- From:
Chinese Journal of Modern Nursing
2018;24(2):143-146
- CountryChina
- Language:Chinese
-
Abstract:
Objective To construct a risk assessment tool of unplanned readmission within 1 year after colorectal cancer surgery in patients under enhanced recovery after surgery (ERAS) mode. Methods A total of 446 patients who were treated in Gastrointestinal Surgery Department of West China Hospital and had been followed up for one year from January 2010 to May 2013 were selected as the research subjects by purposive sampling method. Logistic regression was adopted to analyze the influencing factors of unplanned readmission in colorectal cancer patients under ERAS. Through literature review and retrospective case control study, the risk assessment index of unplanned readmission for 1 year after colorectal cancer surgery in ERAS mode was drawn up, and the index selection and weight assignment were carried out by Delphi expert consultation method. Results The result of Logistic regression analysis showed that complications before first admission was the influencing factor of unplanned readmission in colorectal patients under ERAS(OR=2.91). The recovery rates of the two rounds of expert consultation were 100%, the expert authority coefficient was 0.91, and the expert consultation coordination coefficient was 0.361 (χ2=32.711, P<0.001). Four items of risk assessment indexes were established after two rounds of expert consultation, including: complications before surgery, emergency admission, advanced age and postoperative abnormalities. Conclusions The risk assessment tool for unplanned readmission within one year after colorectal cancer surgery in patients under ERAS mode was constructed with high reliability. It can be used to assess the unplanned readmission risk of patients with colorectal cancer, but its clinical applicability needs to be further verified.
